| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 13.69▼ | 13.70▼ | 13.71▼ | 13.75▼ | 13.77▼ |
| MA10 | 13.69▼ | 13.71▼ | 13.69▼ | 13.74▼ | 14.26▼ |
| MA20 | 13.70▼ | 13.69▼ | 13.72▼ | 13.78▼ | 14.64▼ |
| MA50 | 13.70▼ | 13.76▼ | 13.78▼ | 14.49▼ | 15.28▼ |
| MA100 | 13.75▼ | 13.74▼ | 13.77▼ | 14.79▼ | 16.76▼ |
| MA200 | 13.74▼ | 13.88▼ | 14.18▼ | 15.33▼ | 16.78▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.003▲ | 0.001▲ | 0.037▲ | -0.096▼ |
| RSI | 37.670▼ | 40.049▼ | 39.732▼ | 35.077▼ | 34.496▼ |
| STOCH | 38.095 | 41.178 | 63.233 | 50.673 | 16.674▼ |
| WILL %R | -100.000▼ | -73.333 | -74.074 | -59.615 | -89.552▼ |
| CCI | -61.860 | -67.427 | -17.638 | -49.808 | -104.371▼ |
|
Tuesday, December 09, 2025 08:30 AM
1 Return data is net of all fund expenses and fees and assumes the reinvestment of all distributions reinvested at prices obtained under the Fund's dividend reinvestment plan.2 Based on the Fund's NAV ...
|
|
Monday, January 13, 2025 04:31 AM
Initiating Phase 2b clinical trial in first half of 2025 after achieving a meaningful functional cure rate in cHBV patients treated with imdusiran and interferon WARMINSTER, Pa., Jan. 13, 2025 (GLOBE ...
|
|
Wednesday, December 18, 2024 04:21 AM
Viatris (VTRS) announced the publication of Phase 2b CARE study results evaluating the efficacy and safety of cenerimod in adults with moderate-to-severe systemic lupus erythematosus, or SLE. The ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/12/25 | 13.64 | 13.74 | 13.64 | 13.67 | 313,900 |
| 29/12/25 | 13.67 | 13.70 | 13.64 | 13.66 | 302,900 |
| 26/12/25 | 13.77 | 13.85 | 13.75 | 13.77 | 284,300 |
| 24/12/25 | 13.75 | 13.83 | 13.75 | 13.80 | 117,200 |
| 23/12/25 | 13.75 | 13.87 | 13.75 | 13.84 | 260,500 |
| 22/12/25 | 13.80 | 13.90 | 13.75 | 13.79 | 359,200 |
| 19/12/25 | 13.75 | 13.98 | 13.75 | 13.84 | 269,200 |
| 18/12/25 | 13.65 | 13.79 | 13.65 | 13.71 | 262,000 |
| 17/12/25 | 13.58 | 13.73 | 13.58 | 13.61 | 340,300 |
| 16/12/25 | 13.59 | 13.67 | 13.59 | 13.67 | 264,359 |
|
|
||||
|
|
||||
|
|